Home/Filings/4/0001104659-22-059890
4//SEC Filing

Shemesh Shay 4

Accession 0001104659-22-059890

CIK 0001875558other

Filed

May 12, 8:00 PM ET

Accepted

May 13, 8:30 AM ET

Size

9.8 KB

Accession

0001104659-22-059890

Insider Transaction Report

Form 4
Period: 2022-05-12
Shemesh Shay
Chief Dev. & Ops. Officer
Transactions
  • Purchase

    Common Stock

    2022-05-12$14.58/sh+36$5251,239,651 total
  • Purchase

    Common Stock

    2022-05-12$15.85/sh+1,184$18,7661,240,835 total
  • Purchase

    Common Stock

    2022-05-12$16.61/sh+58$9631,240,893 total
Footnotes (4)
  • [F1]Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.35 to $14.60. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F2]Includes 48,399 shares of restricted stock and 60,000 restricted stock units.
  • [F3]Reflects the weighted average purchase price. The range of prices for the shares purchased was $15.45 to $16.45. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F4]Reflects the weighted average purchase price. The range of prices for the shares purchased was $16.46 to $17.46. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

Issuer

Nuvectis Pharma, Inc.

CIK 0001875558

Entity typeother

Related Parties

1
  • filerCIK 0001896056

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 8:30 AM ET
Size
9.8 KB